GPI SpACHIX:GPIM 78 ROE % is 8.33% as of Dec. 2025, which is 36% below its 10-year median of 13.06. GuruFocus rates CHIX:GPIM with a GF Score™ of 78/100 and a GF Value™ of €18.64. The stock has 4 warning signs investors should review. Among 628 Healthcare Providers & Services companies, GPI SpA ranks worse than 51.27% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. GPI SpA's annualized net income for the quarter that ended in Dec. 2025 was €24.9 Mil. GPI SpA's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was €299.6 Mil. Therefore, GPI SpA's annualized ROE % for the quarter that ended in Dec. 2025 was 8.33%.
The historical rank and industry rank for GPI SpA's ROE % or its related term are showing as below:
CHIX:GPIm'
s ROE % Range Over the Past 10 Years
Min: 2.32 Med: 13.06 Max: 38.53
Current: 5.36
During the past 12 years, GPI SpA's highest ROE % was 38.53%. The lowest was 2.32%. And the median was 13.06%.
CHIX:GPIm's ROE % is ranked worse than 51.27% of 628
companies
in the Healthcare Providers & Services industry
Industry Median: 5.72
vs CHIX:GPIm: 5.36
GPI SpA (CHIX:GPIm) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
GPI SpA ROE % Related Terms
GPI SpA ROE % Historical Data
* Premium members only.
The historical data trend for GPI SpA's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, GPI SpA's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GPI SpA ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, GPI SpA's ROE % distribution charts can be found below:
* The bar in red indicates where GPI SpA's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
GPI SpA (CHIX:GPIM) has a ROE % of 8.33% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on GPI SpA and its competitors. This is 36% below median its historical median of 13.06. Over the past decade, GPI SpA's ROE % has ranged from 2.32 to 38.53. According to the industry distribution chart, GPI SpA ranks #322 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 51.3%.
Is GPI SpA's ROE % too high?
GPI SpA's current ROE % of 8.33% is 36% below median its 10-year median of 13.06. Over the past 10 years, this metric has ranged from a low of 2.32 to a high of 38.53. The Healthcare Providers & Services industry median ROE % is 5.72. GPI SpA's value of 8.33% is 45.6% above this industry median. Based on the distribution chart, GPI SpA ranks #322 out of 628 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, GPI SpA has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does GPI SpA's ROE % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, GPI SpA ranks #322 out of 628 companies for ROE %. This places GPI SpA in the lower half of its industry. The industry median ROE % is 5.72. GPI SpA's value of 8.33% is 45.6% above this benchmark. Historically, GPI SpA's own ROE % has ranged from 2.32 to 38.53 over the past decade. While the company's 10-year median is 13.06 vs. the industry median of 5.72, GPI SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.72, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GPI SpA's current ROE % of 8.33% is 45.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on GPI SpA and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GPI SpA's current ROE % is 8.33%, which is 36% below median its own 10-year median of 13.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GPI SpA stock overvalued right now?
GPI SpA (CHIX:GPIM) has a current ROE % of 8.33%. The stock's GF Value™ is €18.64, compared to a current price of €17.00 — trading 8.8% below its estimated fair value. The current ROE % is 8.33%, which is 36% below median its 10-year median of 13.06 and 45.6% above the Healthcare Providers & Services industry median of 5.72. GPI SpA's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For GPI SpA (CHIX:GPIM), the current ROE % is 8.33% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GPI SpA (CHIX:GPIM) Overvalued in 2026?
Based on GuruFocus' analysis, GPI SpA stock appears to be undervalued.
The current stock price of €17.00 is trading 8.8% below its estimated GF Value™ of €18.64.
Key valuation signals for CHIX:GPIM:
ROE %: 8.33% (36% below median its 10-year median of 13.06)
GF Value™: €18.64 vs. price of €17.00 (8.8% below fair value)
Industry Position: 45.6% above the Healthcare Providers & Services median (#322 of 628)
No single metric tells the full story. See the CHIX:GPIM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GPI SpA operates in the field of social-healthcare IT services and hi-tech services for health. It provides services in the areas of IT systems, healthcare, pharmacy logistics, electronic payment solutions, and ICT infrastructures and systemic services.
78GF Score
Get the complete analysis for CHIX:GPIM
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:GPIM has been successfully added to your 
